Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation

Transplant International

Volumn 23, Issue 3, 2010, Pages 338-340

  Hori, Tomohide ^a,b   Egawa, Hiroto ^a   Takada, Yasutsugu ^a   Oike, Fumitaka ^a   Ogura, Yasuhiro ^a   Ogawa, Kohei ^a   Kaido, Toshimi ^a   Toshimitsu, Yasuko ^a   Yagi, Shintaro ^a   Iida, Taku ^a   Nguyen, Justin H ^b   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; HLA ANTIGEN CLASS 1; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIGEN SPECIFICITY; BACTERIAL PERITONITIS; CASE REPORT; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOTOXICITY TEST; ECCHYMOSIS; FEMALE; GRAFT REJECTION; HEPATITIS C VIRUS; HLA TYPING; HUMAN; IMMUNOREACTIVITY; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE; PLASMAPHERESIS; PLEURISY; PRIORITY JOURNAL; SPLENECTOMY;

FATAL OUTCOME; FEMALE; GRAFT REJECTION; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNITY, HUMORAL; LIVER TRANSPLANTATION; LIVING DONORS; LYMPHOCYTES; MIDDLE AGED; PLASMA EXCHANGE; TIME FACTORS;

EID: 75149162871     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00954.x     Document Type: Letter

References (15)

1. Neumann UP, Lang M, Moldenhauer A, et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001 71: 1163.
2. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003 3: 348.
3. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966 2: 662.
4. Sugawara Y, Makuuchi M, Kaneko J, Kishi Y, Hata S, Kokudo N. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transpl 2003 9: 1062.
5. Ashihara E, Tsuji H, Sakashita H, et al. Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 2007 83: 506.
6. Sakashita H, Haga H, Ashihara E, et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007 20: 676.
7. Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988 46: 372.
8. Donaldson P, Underhill J, Doherty D, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology 1993 17: 1008.
9. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994 58: 786.
10. Tyden G, Kumlien G, Efvergren M. Present techniques for antibody removal. Transplantation 2007 84 (12 Suppl. S27.
11. Hathaway M, Gunson BK, Keogh AC, Briggs D, McMaster P, Neuberger JM. A positive crossmatch in liver transplantation-no effect or inappropriate analysis? A prospective study. Transplantation 1997 64: 54.
12. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008 47: 143.
13. Faguer S, Kamar N, Guilbeaud-Frugier C, et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007 83: 1277.
14. Billing H, Rieger S, Ovens J, et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 2008 86: 1214.
15. Kaplan B, Gangemi A, Thielke J, Oberholzer J, Sankary H, Benedetti E. Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation 2007 83: 99.